July 9, 2019
This morning precision medicine company GNS Healthcare announced a $23 million Series D raise. This latest investment round was led by Cigna Ventures with participation from Amgen Ventures, Celegene, Echo Health Ventures, Alexandria Venture Investments and Gary Loveman, the former CEO of Caesar and division president of Aetna.
WHAT THEY DO
The company’s platform, dubbed REFS (Reverse Engineering...
April 25, 2017
Remote clinical trial company Science 37 has raised $29 million in a round led by Glynn Capital Management with participation from Google's investment arm GV. One more new investor -- AmGen ventures -- contributed, as did existing investors Lux Capital, Redmile Group, dRx Capital, and Sanofi Ventures. It's a large round with impressive investors, but it is technically a down round from last fall'...